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Purpose. To present a case of a keratoconic patient who underwent epithelial removal with transepithelial phototherapeutic
keratectomy (t-PTK) using a 213-nm solid-state laser system followed by corneal collagen cross-linking (CXL) with riboﬂavin
and ultraviolet-A (UVA) irradiation. Methods.C a s er e p o r t .Results. A twenty-four-year-old male with keratoconus underwent
CXL treatment after epithelial removal with t-PTK using a solid-state laser system. No intra- or early postoperative complications
were found. One month postoperatively, uncorrected visual acuity (UCVA) improved from 20/63 to 20/32 while best spectacle-
corrected visual acuity (BSCVA) improved from 20/40 to 20/25. Corneal topography revealed a signiﬁcant improvement which
remained stable during the six-month followup period. Conclusions. Epithelial removal with t-PTK before CXL could improve
patient’s visual outcome.
1.Introduction
Removal of the corneal epithelium is an essential component
of riboﬂavin-ultraviolet-A (UVA) corneal collagen cross-
linking(CXL)therapytopermitthepenetrationofriboﬂavin
into the corneal stroma. Failure to achieve adequate stromal
absorption of riboﬂavin may impair the eﬃcacy of the
cross-linking process [1]; until now epithelial removal is
performed mechanically. Excimer laser phototherapeutic
keratectomy (PTK) is a well-known surgical technique that
has successfully been used in the management of superﬁcial
corneal pathology, such as anterior corneal dystrophies,
degenerations [2], and the treatment of keratoconus nodules
[3]. Transepithelial PTK (t-PTK) uses an Excimer laser
ablation in order to remove the epithelium and smooth the
anterior irregular cornea [4].
In this paper, we present a case of a keratoconic patient
who underwent epithelial removal with t-PTK using a solid-
state laser system followed by CXL treatment with riboﬂavin
and UVA irradiation.
2.CaseReport
A twenty-four-year-old male with progressive keratoconus
presented to our institute for consultation. At the time of the
examination, uncorrected visual acuity (UCVA) was 20/25
in the right and 20/63 in the left eye and best spectacle-
corrected visual acuity (BSCVA) was 20/20 (manifest refrac-
tion plano—1.00 × 15) in the right eye and 20/40 (manifest
refraction—1.25–4.00 × 125) in the left eye. A trial with a
rigidgas-permeablecontactlensdemonstratedimprovement
in visual acuity of 20/20 in his left eye. Keratometric readings
were 42.60 × 24/43.52 × 114 at the right and 47.51 × 46/
56.98 ×136 at the left eye.
In order to assess corneal thickness, a pachymetric map
measurement was performed in the right (481μmc e n t r a l ,
639 nasal, 550 temporal, 587 superior, and 547 inferior)
and left (462μm central, 581 nasal, 569 temporal, 611
superior, and 541 inferior) eye by ultrasound pachymetry
(Sonogage, Cleveland, Ohio, USA). Epithelial thickness at
the apex of the cone was 41μm in the left eye. Slit-lamp2 Journal of Ophthalmology
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Figure 1: Intraoperative photography (a) showing the correlation between the ablated stroma (coarse surface) after transepithelial
phototherapeutic keratectomy (t-PTK) and the preoperative corneal topography (b).
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Figure2:Preoperative(left)andone-monthpostoperative(right)topography(TechnomedC-Scan,Baesweiler,Germany)ofthekeratoconic
patient treated with combined transepithelial phototherapeutic keratectomy and collagen cross-linking with riboﬂavin and UVA irradiation.
examination of anterior and posterior segment showed no
other abnormality.
2.1. Surgical Technique. Epithelium was removed by t-PTK.
A solid-state laser system with a wavelength of 213nm
(Pulzar Z1, CustomVis, Perth, WA) was used for the pro-
cedure. The wavelength is generated using a major Nd:YAG
laser system of 1064nm, and through special cultivated
crystals the 213nm is ﬁnally used. The t-PTK ablation was
performedinan8.0mmzoneinanintendeddepthof50μm.
There was a correlation between the localized ablated stroma
and the preoperative topography (Figure 1). After t-PTK,
riboﬂavin 0.1% solution was instilled every 3 minutes for
approximately 30 minutes. Penetration of the cornea and
presence of riboﬂavin in the anterior chamber (riboﬂavin
shielding) were monitored by slit-lamp examination. UVA
irradiation was performed using a commercially available
UVAopticalsystem(UV-Xilluminationsystemversion1000,
Zurich, Switzerland) with a light source consisting of an
array of UV diodes (365nm) with a potentiometer in series
to allow regulation of voltage. Before treatment, intended
irradiance of 3.0mW/cm2 (5.4J/cm2 surface dose after 30
minutes) was calibrated using the UV-A light meter YK-
34UV (Lutron Electronic) which is supplied with the UV-
X device. Irradiance was performed for 30 minutes, corre-
sponding toadoseof5.4J/cm2.Duringtreatment,riboﬂavin
solution was applied every 5 minutes to saturate the cornea
with riboﬂavin. At the end of the procedure, a silicon-
hydrogelbandagecontactlens(LotraﬁlconB,AirOptix,CibaJournal of Ophthalmology 3
Vision—14.0mm diameter, 8.6 base curvature, and Dk =
140 barrers) was applied until full reepithelialization.
Postoperative medication included diclofenac sodium
0.1% (Denaclof, Novartis) for 2 days as well as anti-
biotic/corticosteroid (tobramycin/dexamethasone) drops
(Tobradex, Alcon Laboratories, Inc.) four times daily until
the removal of the bandage contact lens. The treated left
eye was examined daily until the epithelium was completely
healed. Contact lens was removed at the ﬁfth postoperative
day, and no signs of edema or inﬂammation were cited
by slit-lamp biomicroscopy. After the removal of the
contact lens, the patient received corticosteroid drops (FML,
ﬂuorometholone 0.1%, Falcon Pharmaceuticals), tapering
for the next 15 days, and he was encouraged to use artiﬁcial
tears at least six times per day for 3 months postoperatively.
One month after the combined t-PTK and CXL pro-
cedure, both UCVA and BSCVA were improved at 20/32
and 20/25, respectively (manifest refraction —0.50–2.00 ×
135). Slit-lamp biomicroscopy revealed a clear cornea with
no signs of haze formation. Corneal topography revealed a
signiﬁcant improvement (Figure 2) which remained stable
during the six-month follow-up period.
3. Discussion
Excimer laser phototherapeutic keratectomy (PTK) is a well-
known surgical technique that has successfully been used in
the management of superﬁcial corneal pathology, such as
anterior corneal dystrophies and degenerations [2]. Elsahn
et al. demonstrated the safety and eﬃcacy of PTK in the
treatment of keratoconus nodules and the improvement of
contact lens tolerance in these patients [3]. T-PTK uses an
Excimer laser ablation to remove the epithelium and smooth
the anterior irregular cornea [4].
In this paper, the patient underwent t-PTK using a
solid-state laser system before CXL with riboﬂavin and
UVA irradiation. The aim of t-PTK was epithelial removal
and anterior cornea smoothening in order to decrease the
irregular astigmatism. In keratoconic patients, epithelium
is thinner at the cone apex than centrally [5]. Reinstein
has reported that in a study of 38 keratoconic eyes, an
inferotemporal region of thin epithelium surrounded by
epithelial thickening was found; a pattern coincided with
the cone on topography [6]. According to this keratoconic
pattern, an intended ablation depth of 50μmh a sb e e n
chosen in order to use the patient’s own epithelium as a
masking agent allowing laser ablation to take place on the
apex of the cone to regularize the stromal surface (Figure 1).
The signiﬁcant improvement in visual acuity, especially
in UCVA, from the ﬁrst postoperative month should be
the result of t-PTK which decreases corneal irregularities
as shown at the topography one month postoperatively
(Figure 2). CXL after mechanical epithelial removal could
potentially improve patient’s UCVA but not at the ﬁrst
postoperative month and in this amplitude [7]. A possible
limitation of this approach could be the decrease of corneal
tissue by t-PTK at the cone apex before CXL. This could
increase the possibility of corneal damage from the UVA
irradiation.
In conclusion, epithelial removal with t-PTK before CXL
couldimprovepatient’svisualoutcomes.Longerfollow-upis
necessary in order to evaluate the outcomes of this combined
procedure.
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